Three checkpoints in lupus development: Central tolerance in adaptive immunity, peripheral amplification by innate immunity and end-organ inflammation

Genes and Immunity

Volumn 10, Issue 5, 2009, Pages 390-396

  Kanta, H ^a   Mohan, C ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B LYMPHOCYTE RECEPTOR; CD150 ANTIGEN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 12; INTERLEUKIN 1BETA; KALLIKREIN; TUMOR NECROSIS FACTOR ALPHA;

ADAPTIVE IMMUNITY; B LYMPHOCYTE; CD4 CD8 RATIO; DENDRITIC CELL; GENE AMPLIFICATION; GENE EXPRESSION; GENE LOCUS; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; IMMUNOREACTIVITY; INNATE IMMUNITY; LINKAGE ANALYSIS; LUPUS ERYTHEMATOSUS NEPHRITIS; NERVE ENDING; NONHUMAN; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN CROSS LINKING; REVIEW; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

ANIMALS; HUMANS; IMMUNITY, INNATE; LUPUS ERYTHEMATOSUS, SYSTEMIC; MICE; MICE, CONGENIC;

MURINAE;

EID: 67849126802     PISSN: 14664879     EISSN: 14765470     Source Type: Journal    
DOI: 10.1038/gene.2009.6     Document Type: Review

References (86)

1. Wakeland EK, Wandstrat AE, Liu K, Morel L. Genetic dissection of systemic lupus erythematosus. Curr Opin Immunol 1999; 11: 701-707.
2. Namjou B, Kilpatrick J, Harley JB. Genetics of clinical expression in SLE. Autoimmunity 2007; 40: 602-612.
3. Nath SK, Kilpatrick J, Harley JB. Genetics of human systemic lupus erythematosus: The emerging picture. Curr Opin Immunol 2004; 16 794-800.
4. Wakeland EK, Liu K, Graham RR, Behrens TW. Delineating the genetic basis of systemic lupus erythematosus. Immunity 2001; 15: 397-408.
5. Rudofsky UH, Evans BD, Balaban SL, Mottironi VD, Gabrielsen AE. Differences in expression of lupus nephritis in New Zealand mixed H-2z homozygous inbred strains of mice derived from New Zealand black and New Zealand white mice. Origins and initial characterization. Lab Invest 1993; 68: 419-426.
6. Morel L, Rudofsky UH, Longmate JA, Schiffenbauer J, Wakeland EK. Polygenic control of susceptibility to murine systemic lupus erythematosus. Immunity 1994; 1: 219-229.
7. Morel L, Yu Y, Blenman KR, Caldwell RA, Wakeland EK. Production of congenic mouse strains carrying genomic intervals containing SLE-susceptibility genes derived from the SLE-prone NZM2410 strain. Mamm Genome 1996; 7: 335-339.
8. Morel L, Mohan C, Yu Y, Croker BP, Tian N, Deng A et al. Functional dissection of systemic lupus erythematosus using congenic mouse strains. J Immunol 1997; 158: 6019-6028.
9. Mohan C, Alas E, Morel L, Yang P, Wakeland EK. Genetic dissection of SLE pathogenesis. Sle1 on murine chromosome 1 leads to a selective loss of tolerance to H2A/H2B/DNA subnucleosomes. J Clin Invest 1998; 101: 1362-1372.
10. Sobel ES, Mohan C, Morel L, Schiffenbauer J, Wakeland EK. Genetic dissection of SLE pathogenesis: Adoptive transfer of Sle1 mediates the loss of tolerance by bone marrow-derived B cells. J Immunol 1999; 162: 2415-2421.
11. Mohan C, Morel L, Yang P, Wakeland EK. Genetic dissection of systemic lupus erythematosus pathogenesis: Sle2 on murine chromosome 4 leads to B cell hyperactivity. J Immunol 1997; 159: 454-465.
12. Mohan C, Morel L, Yang P, Wakeland EK. Accumulation of splenic B1a cells with potent antigen-presenting capability in NZM2410 lupus-prone mice. Arthritis Rheum 1998; 41: 1652-1662.
13. Xu Z, Duan B, Croker BP, Wakeland EK, Morel L. Genetic dissection of the murine lupus susceptibility locus Sle2: Contributions to increased peritoneal B-1a cells and lupus nephritis map to different loci. J Immunol 2004; 173: 6050-6058.
14. Mohan C, Yu Y, Morel L, Yang P, Wakeland EK. Genetic dissection of SLE pathogenesis: Sle3 on murine chromosome 7 impacts T cell activation, differentiation, and cell death. J Immunol 1999; 162: 6492-6502.
15. Sobel ES, Morel L, Baert R, Mohan C, Schiffenbauer J, Wakeland EK. Genetic dissection of systemic lupus erythematosus pathogenesis: evidence for functional expression of Sle3/5 by non-T cells. J Immunol 2002; 169: 4025-4032.
16. Mohan C, Morel L, Yang P, Watanabe H, Croker B, Gilkeson G et al. Genetic dissection of lupus pathogenesis: A recipe for nephrophilic autoantibodies. J Clin Invest 1999; 103: 1685-1695.
17. Morel L, Croker BP, Blenman KR, Mohan C, Huang G, Gilkeson G et al Genetic reconstitution of systemic lupus erythematosus immunopathology with polycongenic murine strains. Proc Natl Acad Sci USA 2000; 97: 6670-6675.
18. Shi X, Xie C, Kreska D, Richardson JA, Mohan C. Genetic dissection of SLE: SLE1 and FAS impact alternate pathways leading to lymphoproliferative autoimmunity. J Exp Med 2002; 196: 281-292.
19. Subramanian S, Tus K, Li QZ, Wang A, Tian XH, Zhou J et al. A Tlr7 translocation accelerates systemic autoimmunity in murine lupus. Proc Natl Acad Sci USA 2006; 103: 9970-9975.
20. Shi X, Xie C, Chang S, Zhou XJ, Tedder T, Mohan C. CD19 hyper-expression augments Sle1-induced humoral autoimmunity but not clinical nephritis. Arthritis Rheum 2007; 56: 3057-3069.
21. Kono DH, Theofilopoulos AN. Genetics of systemic autoimmunity in mouse models of lupus. Int Rev Immunol 2000; 19: 367-387.
22. Morel L, Blenman KR, Croker BP, Wakeland EK. The major murine systemic lupus erythematosus susceptibility locus, Sle1, is a cluster of functionally related genes. Proc Natl Acad Sci USA 2001; 98: 1787-1792.
23. Wandstrat AE, Nguyen C, Limaye N, Chan AY, Subramanian S, Tian XH et al. Association of extensive polymorphisms in the SLAM/CD2 gene cluster with murine lupus. Immunity 2004; 21: 769-780.
24. Kumar KR, Li L, Yan M, Bhaskarabhatla M, Mobley AB, Nguyen C et al Regulation of B cell tolerance by the lupus susceptibility gene Ly108. Science 2006; 312: 1665-1669.
25. Chen Y, Perry D, Boackle SA, Sobel ES, Molina H, Croker BP et al. Several genes contribute to the production of autoreactive B and T cells in the murine lupus susceptibility locus Sle1c. J Immunol 2005; 175: 1080-1089.
26. Boackle SA, Holers VM, Chen X, Szakonyi G, Karp DR, Wakeland EK et al. Cr2, a candidate gene in the murine Sle1c lupus susceptibility locus, encodes a dysfunctional protein. Immunity 2001; 15: 775-785.
27. Wu X, Jiang N, Deppong C, Singh J, Dolecki G, Mao D et al. A role for the Cr2 gene in modifying autoantibody production in systemic lupus erythematosus. J Immunol 2002; 169: 1587-1592.
28. Giles BM, Tchepeleva SN, Kachinski JJ, Ruff K, Croker BP, Morel L et al. Augmentation of NZB autoimmune phenotypes by the Sle1c murine lupus susceptibility interval. J Immunol 2007; 178: 4667-4675.
29. Banchereau J, Steinman RM. Dendritic cells and the control of immunity. Nature 1998; 392: 245-252.
30. Stetson DB, Medzhitov R. Type I interferons in host defense. Immunity 2006; 25: 373-381.
31. Meylan E, Tschopp J, Karin M. Intracellular pattern recognition receptors in the host response. Nature 2006; 442: 39-44.
32. Vyse TJ, Kotzin BL. Genetic susceptibility to systemic lupus erythematosus. Annu Rev Immunol 1998; 16: 261-292.
33. Kong PL, Morel L, Croker BP, Craft J. The centromeric region of chromosome 7 from MRL mice (Lmb3) is an epistatic modifier of Fas for autoimmune disease expression. J Immunol 2004; 172: 2785-2794.
34. Wakui M, Kim J, Butfiloski EJ, Morel L, Sobel ES. Genetic dissection of lupus pathogenesis: Sle3/5 impacts IgH CDR3 sequences, somatic mutations, and receptor editing. J Immunol 2004; 173: 7368-7376.
35. Zhu J, Liu X, Xie C, Yan M, Yu Y, Sobel ES et al. T cell hyperactivity in lupus as a consequence of hyperstimulatory antigen-presenting cells. J Clin Invest 2005; 115: 1869-1878.
36. Ding D, Mehta H, McCune WJ, Kaplan MJ. Aberrant phenotype and function of myeloid dendritic cells in systemic lupus erythematosus. J Immunol 2006; 177: 5878-5889.
37. Blanco P, Palucka AK, Gill M, Pascual V, Banchereau J. Induction of dendritic cell differentiation by IFN-alpha in systemic lupus erythematosus. Science 2001; 294: 1540-1543.
38. Murphy ED, Roths JB. A Y chromosome associated factor in strain BXSB producing accelerated autoimmunity and lymphoproliferation. Arthritis Rheum 1979; 22: 1188-1194.
39. Izui S. Autoimmune accelerating genes, lpr and Yaa, in murine systemic lupus erythematosus. Autoimmunity 1990; 6: 113-129.
40. Steinberg RT, Miller ML, Steinberg AD. Effect of the BXSB Y chromosome accelerating gene on autoantibody production. Clin Immunol Immunopathol 1985; 35: 67-72.
41. Hudgins CC, Steinberg RT, Klinman DM, Reeves MJ, Steinberg AD. Studies of consomic mice bearing the Y chromosome of the BXSB mouse. J Immunol 1985; 134: 3849-3854.
42. Izui S, Higaki M, Morrow D, Merino R. The Y chromosome from autoimmune BXSB/MpJ mice induces a lupus-like syndrome in (NZW x C57BL/6) F1 male mice, but not in C57BL/6 male mice. Eur J Immunol 1988; 18: 911-915.
43. Pisitkun P, Deane JA, Difilippantonio MJ, Tarasenko T, Satterthwaite AB, Bolland S. Autoreactive B cell responses to RNA-related antigens due to TLR7 gene duplication. Science 2006; 312: 1669-1672.
44. Rozzo S, Allard J, Choubey D, Vyse T, Izui S, Peltz G et al. Evidence for an interferon-inducible gene, Ifi202, in the susceptibility to systemic lupus. Immunity 2002; 15: 435-443.
45. Xin H, D'Souza S, Jorgensen TN, Vaughan AT, Lengyel P, Kotzin BL et al. Increased expression of Ifi202, an IFN-activatable gene, in B6.Nba2 lupus susceptible mice inhibits p53-mediated apoptosis. J Immunol 2006; 176: 5863-5870.
46. Panchanathan R, Xin H, Choubey D. Disruption of mutually negative regulatory feedback loop between interferon-inducible p202 protein and the E2F family of transcription factors in lupus-prone mice. J Immunol 2008; 180: 5927-5934.
47. Yu D, Tan AH, Hu X, Athanasopoulos V, Simpson N, Silva DG et al. Roquin represses autoimmunity by limiting inducible T-cell co-stimulator messenger RNA. Nature 2007; 450: 299-303.
48. Gubbels MR, Jørgensen TN, Metzger TE, Menze K, Steele H, Flannery SA et al. Effects of MHC and gender on lupus-like autoimmunity in Nba2 congenic mice. Immunol 2005; 175: 6190-6196.
49. Morel L, Tian XH, Croker BP, Wakeland EK. Epistatic modifiers of autoimmunity in a murine model of lupus nephritis. Immunity 1999; 11: 131-139.
50. Hahn BH. Antibodies to DNA. N Engl J Med 1998; 338: 1359.
51. Lefkowith JB, Gilkeson GS. Nephritogenic autoantibodies in lupus. Current concepts and continuing controversies. Arthritis Rheum 1996; 39: 894.
52. Tang T, Rosenkranz A, Assmann KM, Goodman MJ, Gutierrez-Ramos JC, Carroll MC et al. A role for Mac-1 (CDllb/CD18) in immune complex-stimulated neutrophil function in vivo: Mac-1 deficiency abrogates sustained Fcgamma receptor-dependent neutrophil adhesion and complement-dependent proteinuria in acute glomerulonephritis. J Exp Med 1997; 186: 1853.
53. Hebert MJ, Takano T, Papayianni A, Rennke HG, Minto A, Salant DJ et al. Acute nephrotoxic serum nephritis in complement knockout mice: relative roles of the classical and alternate pathways in neutrophil recruitment and proteinuria. Nephrol Dial Transplant 1998; 13 2799.
54. Suzuki Y, Shirato I, Okumura K, Ravetch JV, Takai T, Tomino Y et al Distinct contribution of Fc receptors and angiotensin II-dependent pathways in anti-GBM glomerulonephritis. Kidney Int 1998; 54 1166.
55. Clynes R, Dumitru C, Ravetch JV. Uncoupling of immune complex formation and kidney damage in autoimmune glomerulonephritis. Science 1998; 279: 1052.
56. Le Hir M, Haas C, Marino M, Ryffel B. Prevention of crescentic glomerulonephritis induced by anti-glomerular membrane antibody in tumor necrosis factor-deficient mice. Lab Invest 1998; 78: 1625.
57. Janssen U, Ostendorf T, Gaertner S, Eitner F, Hedrich HJ, Assmann KJ et al. Improved survival and amelioration of nephrotoxic nephritis in intercellular adhesion molecule-1 knockout mice. J Am Soc Nephrol 1998; 9: 1805.
58. Quintero-Del-Rio AI, Kelly JA, Kilpatrick J, James JA, Harley JB. The genetics of systemic lupus erythematosus stratified by renal disease: linkage at 10q22.3 (SLEN1), 2q34-35 (SLEN2), and 11p15.6 (SLEN3). Genes Immun 2002; 3(Suppl 1): S57-S62.
59. Bakkaloglu A, Soylemezoglu O, Tinaztepe K, Saatci U, Soylemezoglu F. Familial membranoproliferative glomerulo-nephritis. Nephrol Dial Transplant 1995; 10: 21-24.
60. Nowack R, Lehmann H, Flores-Suarez LF, Nanhou A, van der Woude FJ. Familial occurrence of systemic vasculitis and rapidly progressive glomerulonephritis. Am J Kidney Dis 1999; 34: 364-373.
61. Kaplan JM, Kim SH, North KN, Rennke H, Correia LA, Tong HO et al. Mutations in ACTN4, encoding alpha-actinin-4, cause familial focal segmental glomerulosclerosis. Nat Genet 2000; 24: 251-256.
62. Freedman BI, Spray BJ, Tuttle AB, Buckalew Jr VM. The familial risk of end-stage renal disease in African Americans. Am J Kidney Dis 1993; 21: 387-393.
63. Freedman BI, Tuttle AB, Spray BJ. Familia/predisposition to nephropathy in African-Americans with non-insulin-dependent diabetes mellitus. Am J Kidney Dis 1995; 25: 710-713.
64. Freedman BI, Wilson CH, Spray BJ, Tuttle AB, Olorenshaw IM, Kammer GM. Familial clustering of end-stage renal disease in blacks with lupus nephritis. Am J Kidney Dis 1997; 29: 729-732.
65. Bergman S, Key BO, Kirk KA, Warnock DG, Rostant SG. Kidney disease in the first-degree relatives of African-Americans with hypertensive end-stage renal disease. Am J Kidney Dis 1996; 27: 341-346.
66. Masugi M. Glomerulonephritis durch das spezifische anti-nierenserum: Ein Beitrag zur Pathogenese der diffusen Glomerulonephritis. Beitr Pathol Anat Allg Pathol 1934; 92: 429.
67. Fu Y, Yong D, Mohan C. The experimental anti-GBM model as a tool for studying spontaneous lupus nephritis. Clin Immunol 2007; 124 109-118.
68. Liu K, Li QZ, Delgado-Vega AM, Abelson AK, Sanchez E, Kelly JA et al Kallikreins as disease genes in anti-GBM disease and lupus nephritis. J Clin Invest 2008 (in press).
69. Rhodes B, Vyse TJ. The genetics of SLE: An update in the light of genome-wide association studies. Rheumatology 2008; 47: 1603-1611.
70. Yokoyama K, Su I, Tezuka T, Yasuda T, Mikoshiba K, Tarakhovsky A et al. BANK regulates BCR-induced calcium mobilization by promoting tyrosine phosphorylation of IP3 receptor. EMBO J 2002; 21: 83-92.
71. Dymecki SM, Zwollo P, Zeller K, Kuhajda FP, Desiderio SV. Structure and developmental regulation of the B-lymphoid tyrosine kinase gene blk. J Biol Chem 1992; 267: 4815-4823.
72. Wasserman R, Li YS, Hardy RR. Differential expression of the blk and ret tyrosine kinases during B lineage development is dependent on Ig rearrangement. J Immunol 1995; 155: 644-651.
73. Carroll MC. The role of complement in B cell activation and tolerance. Adv Immunol 2000; 74: 61-88.
74. Sohn JH, Bora PS, Suk HJ, Molina H, Kaplan HJ, Bora NS. Tolerance is dependent on complement C3 fragment iC3b binding to antigen-presenting cells. Nat Med 2003; 9: 206-212.
75. Wardemann H, Yurasov S, Schaefer A, Young JW, Meffre E, Nussenzweig MC. Predominant autoantibody production by early human B cell precursors. Science 2003; 301: 1374-1377.
76. Yurasov S, Wardemann H, Hammersen J, Tsuiji M, Meffre E, Pascual V et al. Defective B cell tolerance checkpoints in systemic lupus erythematosus. J Exp Med 2005; 201: 703-711.
77. Boone DL, Turer EE, Lee EG, Ahmad R-C, Wheeler MT, Tsui C et al. The ubiquitin-modifying enzyme A20 is required for termination of Toll-like receptor responses. Nat Immunol 2004; 5: 1052-1060.
78. Schoenemeyer A, Barnes BJ, Mancl ME, Latz E, Goutagny N, Pitha PM et al. The interferon regulatory factor, IRF5, is a central mediator of Toll-like receptor 7 signaling. J Biol Chem 2005; 280: 17005-17012.
79. Stuber E, Strober W. The T cell-B cell interaction via OX40-OX40L is necessary for the T cell-dependent humoral immune response. J Exp Med 1996; 183: 979-989.
80. Gregersen PK, Lee H-S, Batliwalla F, Begovich AB. PTPN22: Setting thresholds for autoimmunity. Semin Immunol 2006; 18: 214-223.
81. Nishimura H, Honjo T. PD-1: An inhibitory immunoreceptor involved in peripheral tolerance. Trends Immunol 2001; 22: 265-268.
82. Stetson DB, Joan S, Ko JS, Heidmann T, Medzhitov R. Trex1 prevents cell-intrinsic initiation of autoimmunity. Cancer Cell 2008; 134: 587-598.
83. Jacob CO, Zang S, Li L, Ciobanu V, Quismorio F, Mizutani A et al. Pivotal role of Stat4 and Stat6 in the pathogenesis of the Lupus-like disease in the New Zealand mixed 2328 mice. J Immunol 2003; 171 1564-1571.
84. Quigg RJ, Kozono Y, Berthiaume D, Lim A, Salant DJ, Weinfeld A et al Blockade of antibody-induced glomerulonephritis with Crry-Ig, a soluble murine complement inhibitor. J Immunol 1998; 160: 4553-4560.
85. Cochrane CG, Unanue ER, Dixon FJ. A role of polymorphonuclear leukocytes and complement in nephrotoxic nephritis. J Exp Med 1965; 122 99-116.
86. Dunne JL, Collins RG, Beaudet AL, Ballantyne CM, Ley K. Mac-1, but not LFA-1, uses intercellular adhesion molecule-1 to mediate slow leukocyte rolling in TNF-alpha-induced inflammation. J Immunol 2003; 171 6105-6111.